Related Experiment Video
Updated: May 27, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cardiovascular comorbidities in Chinese inpatients with schizophrenia spectrum disorders
Zhe Dong1, Gang Wu2, Hongbing Liu3
1Peking University HuiLongGuan Clinical Medical School, Beijing Huilongguan Hospital, Beijing, China.
Insights
Cardiovascular diseases (CVDs) in schizophrenia spectrum disorders (SSDs) show distinct patterns, including hypertension and heart failure. Male sex and specific antipsychotics are linked to higher CVD risks in these patients.
Area of Science:
- Psychiatry
- Cardiology
- Public Health
Background:
- Cardiovascular diseases (CVDs) are a primary cause of premature death in individuals with schizophrenia spectrum disorders (SSDs).
- Understanding CVD comorbidity patterns in SSD patients is crucial for targeted interventions.
- Previous research has not sufficiently detailed these comorbidity patterns.
Purpose of the Study:
- To identify distinct patterns of CVD comorbidity among inpatients with SSDs.
- To investigate factors associated with these identified CVD comorbidity patterns.
Main Methods:
- Latent class analysis (LCA) was used to identify comorbidity patterns from electronic medical records (EMRs) of 2830 Chinese inpatients (2015-2023).
- Multinomial logit analysis assessed the influence of various factors on these patterns, calculating odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- Four distinct CVD comorbidity patterns were identified: low-risk CVDs (47.86%), primary hypertension (30.15%), heart failure (12.99%), and cardiac valve and vascular disorders (8.99%).
- Male patients had a higher likelihood of primary hypertension (OR=1.15) and heart failure (OR=5.36) compared to the low-risk group.
- Comorbid CVDs were associated with the use of typical and atypical antipsychotics, anxiolytics, sedatives, antidepressants, and mood stabilizers. Perphenazine (OR=22.06) and chlorpromazine hydrochloride (OR=7.09) showed strong links to heart failure.
Conclusions:
- Four distinct CVD comorbidity patterns exist in Chinese patients with SSDs, with hypertension and heart failure being prominent.
- Demographic variations and psychotropic medication use are significantly associated with these CVD patterns.
- These findings offer valuable insights for optimizing the clinical management and treatment strategies for comorbid CVDs in SSD patients.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of premature mortality in patients with schizophrenia spectrum disorders (SSDs). However, the detailed categorization of these conditions remains insufficiently explored. This study aims to identify CVDs comorbidity patterns among inpatients with SSDs and to investigate associated factors. Electronic medical records (EMRs) data from three neuropsychiatric hospitals (2015-2023) in China was conducted. Comorbidity patterns were revealed through latent class analysis (LCA), and multinomial logit analysis were utilized to evaluate the effect of factors on these patterns, calculating odds ratios (ORs) and 95% confidence intervals (CIs). Among the 2830 inpatients with SSD, four distinct comorbidity patterns were identified based on their dominant characteristics: low-risk CVDs (47.86%), primary hypertension (30.15%), heart failure (12.99%), and cardiac valve and vascular disorders (8.99%). Compared to the low-risk CVD group, male patients demonstrated a higher probability of primary hypertension (OR = 1.15) and heart failure (OR = 5.36). Significant associations were observed between comorbid CVDs and the use of typical antipsychotics, atypical antipsychotics, anxiolytics and sedatives, antidepressants, and mood stabilizers. Notably, perphenazine (OR = 22.06) and chlorpromazine hydrochloride (OR = 7.09) were strongly linked to comorbid heart failure. Among Chinese patients with SSDs, four distinct CVD comorbidity patterns were identified, with hypertension and heart failure displaying strong specificity. Variations in demographic characteristics and psychotropic medication use provide valuable insights for treatment and management.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

